a.malinowski
Submits third-party assay reports on material purchased directly. Based in Linköping.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.72%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041297 | Semaglutide | WWB | WWB-2603-N3120 | PeptideMeter | 2026-Q2 | 98.63 | 7.02 | 93.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042208 | Retatrutide | TFC | TFC-2508-V8915 | Kestrel | 2026-Q1 | 98.64 | 3.70 | 103.5 | Buyer-sourced | 0 | PASS |
| AX-2025-019709 | Retatrutide | Homopeptide | HOMO-2508-Y3248 | Janoshik | 2025-Q4 | 98.23 | 7.54 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020661 | Tirzepatide | SGN | SGN-2506-J8349 | Kestrel | 2025-Q3 | 98.58 | 1.95 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018603 | N-Acetyl Semax Amide | QYB | QYB-2501-C5179 | Janoshik | 2025-Q2 | 99.68 | 6.13 | 97.9 | Laboratory-retained | 0 | PASS |
| AX-2025-020440 | Semax | KP | KP-2502-H5248 | Janoshik | 2025-Q2 | 99.10 | 7.09 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004272 | AOD-9604 | QSC | QSC-2406-G5496 | Janoshik | 2024-Q3 | 99.89 | 6.00 | 92.8 | Buyer-sourced | 0 | PASS |
| AX-2024-005152 | Tirzepatide | SGN | SGN-2401-K9783 | Janoshik | 2024-Q2 | 98.15 | 3.83 | 92.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004903 | BPC-157 | ERP | ERP-2402-D9383 | VendorInvestigate | 2024-Q2 | 98.81 | 6.75 | 96.4 | Buyer-sourced | 0 | PASS |
| AX-2024-004615 | PT-141 (Bremelanotide) | TFC | TFC-2310-J1196 | Janoshik | 2024-Q1 | 99.84 | 7.71 | — | Buyer-sourced | 0 | PASS |